AI & Data Science
Biomedical analytics, predictive modeling, and intelligent research workflows.
Oncology • Biotechnology • Precision Medicine
Advancing Oncology
Survival Analytics
for Precision Medicine
Delivering specialized oncology survival analytics, scientific consulting, and translational research solutions built on deep biomedical and quantitative expertise.
First launch may take up to 60 seconds while the application wakes up.
SCIENTIFIC CONSULTING & RESEARCH STRATEGY
From Scientific Questions to Better Decisions
Independent scientific perspective, thoughtful study design, and rigorous analysis to support clearer, more confident research decisions.
Scientific Review
Study Design
Data Analysis
Decision Support
Some research decisions benefit from an independent scientific perspective before valuable time and resources are committed.
Accelerate Your Research科学咨询 · 独立视角
从科学问题到更好的科学决策
通过独立的科学视角、严谨的研究设计和科学分析，为科研工作提供更加清晰、更有信心的科学决策支持。
科学审视
研究设计
数据分析
决策支持
在投入宝贵的时间与资源之前，一些重要的科研决策，往往能够从独立的科学视角中获得更多启发。
科研助力About GenMabs
Scientific depth. Forward-looking innovation.
Founded2018Georgia, United States
Our Story
Founded in 2018, GenMabs LLC is a biotechnology company headquartered in Georgia, United States. Since its establishment, the company has been committed to advancing biomedical innovation through scientific research, data science, and emerging technologies. Today, GenMabs integrates artificial intelligence with precision medicine to develop practical solutions that support biomedical research, clinical decision-support, and healthcare innovation.
Looking Ahead
GenMabs will continue expanding its work across artificial intelligence, precision medicine, scientific consulting, biomedical research, and translational medicine, with the goal of accelerating the transformation of scientific discoveries into real-world healthcare innovations. Our long-term vision is to bridge rigorous research and meaningful healthcare impact through responsible technologies, strong evidence, and collaborative partnerships.
Our Focus
A platform for long-term biotechnology growth
Precision Medicine
Tools that help translate patient and cohort data into actionable scientific insight.
Scientific Consulting
Research strategy, experimental design, biomedical analytics, and translational planning.
Explore consulting →Biotechnology Innovation
Long-term opportunities in diagnostics, biomarkers, therapeutic antibodies, and research products.
Featured Product
Now Available
OncoAI™
AI-Powered Cancer Survival Prediction Platform
OncoAI is our first-generation clinical AI platform designed to support researchers and healthcare professionals in analyzing cancer survival risk using statistical modeling, machine learning, and cohort-level analytics.
Individual prediction
Batch prediction
Survival analysis
Risk stratification
Export-ready cohort reports
Technology
Where AI meets biotechnology
Artificial Intelligence
Machine learning, statistical modeling, and intelligent software for biomedical data interpretation.
Clinical Data Science
Risk modeling, survival analysis, cohort analytics, and decision-support workflows.
Biotechnology R&D
Future programs in therapeutic antibodies, biomarker discovery, diagnostics, and AI-assisted drug discovery.
Pipeline
Software today. Broader biomedical innovation tomorrow.
Current
OncoAI™
Clinical AI platform for cancer survival prediction and cohort analytics.
In Development
TumorGPT™
AI assistant concept for oncology research, biomedical interpretation, and precision medicine workflows.
Now Available
Scientific Research Consulting
Integrated support in research strategy, experimental design, biostatistics, biomedical data science, and AI-driven research.
Future Programs
Broader Biomedical Innovation
Potential programs in diagnostics, therapeutic antibodies, biomarkers, research products, and AI-assisted drug discovery.
Responsible Innovation
GenMabs develops research and decision-support technologies. OncoAI outputs are intended for research, evaluation, and decision-support contexts and should not be used as the sole basis for diagnosis, treatment, or other direct clinical decisions.
Contact
GenMabs LLC
Biotechnology company founded in 2018 and based in Georgia, United States.
Scientific Consulting
Need a stronger research direction, study design, or analysis plan?
GenMabs provides integrated consulting in research strategy, experimental design, biostatistics, survival analysis, TCGA/GDC data science, and AI-driven biomedical research.
Collaboration
Interested in partnering with GenMabs?
Learn about complimentary product training, professional materials, live demonstrations, technical support, referral rewards, and opportunities for long-term scientific collaboration.